Not sure which peptide fits your goal? Take the 60 second match

Category hub

HGH peptides,
decoded.

Six molecules, one misunderstood law, and a very large gap between what is measured and what is promised.

Sermorelin compounded vial
Reviewed for medical accuracy · Sources at the end of this page

The short answer

There is no such thing as an HGH peptide. The phrase covers a family of compounds that ask your own pituitary to release more growth hormone, which is a different thing from injecting the hormone itself. They exist because the law made the direct route unavailable to almost everyone, and the entire market you are reading about grew in that gap.

Two familiesGHRH analogs, ghrelin mimetics
Approved memberTesamorelin
How they actYour own pituitary releases the hormone
PrescriptionRequired for every one of them

Why secretagogues exist

Growth hormone is one of the most tightly restricted drugs in American medicine. Federal law limits prescribing and distributing human growth hormone to treatment of a disease or condition for which the FDA has approved it, and anti-aging, athletic performance and body composition in a healthy adult are not on that list. Distributing HGH outside those uses is a federal offense, not a gray area, and prosecutions have followed.

That restriction is the reason the secretagogue category exists at all. Clinics cannot lawfully prescribe growth hormone for feeling younger, so they prescribe compounds that nudge your pituitary to make a bit more of your own. It is a legal workaround before it is a medical strategy, and understanding that explains most of the marketing you will encounter.

The family tree

Everything in this category falls into one of two groups, and they act on different receptors. Knowing which group a molecule belongs to tells you most of what you need about it.

  • GHRH analogs — copies of the natural hormone that tells the pituitary to release growth hormone. Sermorelin is the short-acting original. CJC-1295 is the long-acting version built to survive far longer in the bloodstream. Tesamorelin is the stabilized analog that went through real trials and won FDA approval for visceral fat reduction in HIV-associated lipodystrophy.
  • Ghrelin mimetics — they act on a separate receptor, the one ghrelin uses, and amplify the pulse from the other direction. Ipamorelin is the selective, clean-profile member. Hexarelin is the older and stronger one, with more effect on cortisol and prolactin, which is why it fell out of favor.
  • MK-677 is not a peptide. Ibutamoren is an orally active small molecule that hits the same ghrelin receptor. It raises growth hormone and IGF-1 convincingly and comes with appetite increase, water retention and reported effects on insulin sensitivity. It is not approved for any use, and it sits on the World Anti-Doping Agency list.
  • The combination logic — pairing a GHRH analog with a ghrelin mimetic pushes both levers at once, which is why the CJC-1295 with ipamorelin stack became the default clinic protocol. The synergy is real in hormone measurements. Outcome data in healthy adults is another matter.

Side by side

What it isEvidenceLegal statusTypical monthly cost
SermorelinShort-acting GHRH analog, daily at nightOld pediatric diagnostic and treatment history, thin modern adult outcome dataNot FDA approved, compounded on prescription50 to 150 dollars advertised
CJC-1295 with ipamorelinLong-acting GHRH analog plus selective ghrelin mimeticRaises growth hormone and IGF-1 reliably, no outcome trials in healthy adultsNeither approved, compounded on prescription150 to 350 dollars advertised
TesamorelinStabilized GHRH analog, the only approved onePhase 3 trials, roughly 15 percent visceral fat reduction in its approved populationFDA approved for HIV-associated lipodystrophySpecialty pharmacy pricing, not tracked here
Real HGHThe hormone itself, injected directlyDecades of trials in deficiency, and the effect everything else is compared againstApproved, restricted by federal law to specific diagnosesSpecialty pharmacy pricing, not tracked here

Why pulses matter

Your pituitary does not release growth hormone in a steady stream. It fires in bursts, mostly at night, and the size and spacing of those bursts is regulated by feedback from IGF-1 and by somatostatin, the brake. Injecting growth hormone overrides that system: the level goes where the syringe puts it, the body's own production is suppressed, and side effects such as fluid retention, joint pain, carpal tunnel symptoms and insulin resistance follow the excess.

A secretagogue works inside the system instead of over it. It asks for a bigger pulse, the brake still applies, and IGF-1 feedback still limits the ceiling. That is the honest philosophical case for this category and it is a real one — the pattern is more physiological and the side effect profile in practice is milder. It is also the reason the effect is smaller. You cannot have a gentler intervention and expect the results of a stronger one, and any clinic selling you both halves of that sentence is selling.

A secretagogue only works if your pituitary can still respond. In genuine growth hormone deficiency, where the gland is the problem, these compounds have nothing to work with.

Who this suits

Tesamorelin for its approved indication is the clearest case in the category, and it is not a lifestyle prescription. Beyond that, the people who get something out of secretagogues tend to share a pattern: middle-aged, measurably low IGF-1 for their age, sleeping badly, already training and eating properly, and willing to treat this as a slow three to six month experiment monitored with bloodwork. Sleep quality and recovery are the changes users report most consistently, and they are also the hardest to separate from expectation without a control group.

What a physician contributes here is not the prescription. It is the workup first — IGF-1 measured, thyroid and metabolic panel checked, cancer history taken seriously, and an honest read on whether the symptom you are chasing has a better-documented cause.

Who wastes money

  • Anyone expecting the HGH result. If the goal is what growth hormone does at supraphysiological doses, no secretagogue delivers it, and the ones that came closest are the ones with the worst side effect profiles.
  • Anyone hoping to get taller. Once the growth plates in your bones close at the end of puberty, no hormone and no peptide adds height. More growth hormone in an adult thickens tissue, it does not lengthen bone.
  • Anyone not sleeping. The biggest natural growth hormone pulse happens in deep sleep. Paying 250 dollars a month to amplify a pulse you are cutting short every night is the most common wasted spend in this category.
  • Anyone buying vials online. Research use only labeling is a legal disclaimer, not a quality standard, and independent testing of gray-market peptide vials has repeatedly found wrong doses and contamination.
  • Tested athletes. Growth hormone secretagogues are prohibited at all times under the World Anti-Doping Agency list. There is no dose or timing that makes this safe for a tested competitor.

See how the doctor path works

Questions people ask

Do HGH peptides actually work?
They do what they are designed to do, which is raise growth hormone and IGF-1. That part is measurable and repeatable. Whether it delivers the body composition, energy and anti-aging results people buy them for is much less certain, because outside tesamorelin in its approved population there are almost no outcome trials in healthy adults. Expect a small, slow change that shows up in bloodwork before it shows up anywhere else.
Are HGH peptides legal?
It depends on the molecule. Tesamorelin is FDA approved. Sermorelin, CJC-1295 and ipamorelin are unapproved compounds that reach patients through compounding pharmacies on a valid prescription, a route regulators have narrowed in recent years. MK-677 is approved for nothing. Vials bought online under research use labeling sit outside the lawful supply chain no matter what the label says.
What is the closest thing to real HGH?
Real HGH. Nothing in the secretagogue category matches it, because the whole design principle is to stay inside your own feedback system rather than override it. Among the alternatives, MK-677 raises IGF-1 the most stubbornly and carries the most metabolic baggage, and a GHRH analog paired with a ghrelin mimetic is the most common clinic answer. Both produce a smaller effect than the hormone itself, by design.
Do HGH peptides make you taller?
Not in an adult. Height comes from growth plates at the ends of long bones, and once those fuse at the end of puberty no hormone reopens them. Growth hormone in adults affects soft tissue, fluid and body composition. In children with diagnosed deficiency, growth hormone treatment is a real pediatric therapy, prescribed and monitored by an endocrinologist.
Are peptides safer than HGH?
In principle, and for a reason that makes sense. Secretagogues work through your pituitary, so IGF-1 feedback and somatostatin still cap how high things go, which limits the fluid retention, joint pain and insulin resistance that come with excess hormone. The catch is that safer here mostly means weaker, and it is not the same as studied. Long-term safety data in healthy adults is thin for the whole category.

Sources: PubMed — growth hormone secretagogues · PubMed — tesamorelin and visceral fat · US Code — growth hormone distribution limits